Your search for Warfarin returned 8 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Elizabeth Gough-Gordon, MPR Digital Content Editor remove
Post remove

Your search for Warfarin returned 8 results

Sort Results:

Relevant Recent

Study: Triple Therapy No Better Than Dual for Acute MI, A-Fib

Clinicians should carefully consider the risks and benefits of triple therapy, as new research reports that in older patients with acute myocardial infarction (MI) and atrial fibrillation (AF), triple therapy did not reduce the risk of major cardiovascular events but was associated with a greater risk of bleeding.

IPF Guidelines Updated With New Recs for Rx Therapy

Updated guidelines on the treatment of idiopathic pulmonary fibrosis (IPF) by the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association have been published in the American Journal of Respiratory and Critical Care Medicine.

Using Genetics to Tailor Anticoagulant Therapy

Patients with a genetic sensitivity to warfarin may have higher rates of bleeding during the first several months of treatment and could benefit from therapy with an alternate anticoagulant medication, reports a new study in The Lancet.

Anticoagulant Savaysa Now Available for Prescribing

Daiichi Sankyo announced that Savaysa (edoxaban) tablets are now available to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF), and for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5-10 days of initial therapy with a parenteral anticoagulant.